Tenofovir Alafenamide Succinate

Records for this ingredient, by country (identity only).

ATC J05AF13 · 1 markets · 2 records

Tenofovir Alafenamide Succinate 1 markets · 2 records Forms
Filters
MarketAU 2
Kind

AU 2 records · 1 shown of 1 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

Combination products containing this ingredient

  • 31.194 mgtablet CombinationEmtricitabine 200 mg + Rilpivirine Hydrochloride 27.5 mg + Tenofovir Alafenamide Succinate 31.194 mgRILPEMVI emtricitabine 200 mg, rilpivirine (as hydrochloride) 25 mg, tenofovir alafenamide (as succinate) 25 mg tablet bottleTRILPIVI emtricitabine 200 mg, rilpivirine (as hydrochloride) 25 mg, tenofovir alafenamide (as succinate) 25 mg tablet bottle unknown
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.